ConductScience.org, home

Comparison · NCT04290975-0a02008e

Task-shifted Epilepsy Care Arm (TSC) vs Enhanced Usual Epilepsy Care Arm (EUC): Mortality

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

2 sourcestrial-comparisons-2026-03-23-0.1.0

Download JSON
Cite this record

ConductScience Library. Task-shifted Epilepsy Care Arm (TSC) vs Enhanced Usual Epilepsy Care Arm (EUC): Mortality. Trial comparisons, record NCT04290975-0a02008e. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT04290975-0a02008e

On this page

Measures6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

MeasureValue95% interval, lower95% interval, upperMethodNote
Risk in group 10.05910.04510.0771wilson
Risk in group 20.06540.05040.0843wilson
Risk difference, group 1 minus group 2-0.00627-0.02980.0171newcombe hybrid score
Risk ratio, group 1 over group 20.9040.6231.31log
Odds ratio, group 1 over group 20.8980.6041.34log
Number needed to treat, for one fewer participant with the outcome on Task-shifted Epilepsy Care Arm (TSC) than on Enhanced Usual Epilepsy Care Arm (EUC)159from the risk difference intervalthe interval includes no difference

Groups2

Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.

GroupTitleDescriptionWith the outcomeAnalysedClinicalTrials.gov code
Group 1Task-shifted Epilepsy Care Arm (TSC)
In the task-shifted arm composed of thirty clusters, each cluster being a primary healthcare center (PHC) serving a local community, all children who screened positive for untreated epilepsy underwent a diagnostic evaluation by an epilepsy-trained community health worker (CHW), supervised remotely by a physician with epilepsy expertise. Children who were diagnosed with untreated epilepsy after screening positive for epilepsy were prescribed anti-seizure medication (ASM) by the epilepsy-trained CHW according to a task-shifted protocol, and received follow-up care from an epilepsy-trained CHW, according to the specified task-shifted epilepsy protocol. These epilepsy-trained CHWs were supervised remotely by physicians with expertise in epilepsy, and were able to consult physicians with questions on an as-needed basis.
50846OG000
Group 2Enhanced Usual Epilepsy Care Arm (EUC)
In the enhanced usual care arm composed of thirty clusters, each cluster being a primary healthcare center (PHC) serving a local community, all children who screened positive for epilepsy were referred to a physician according to standard medical practice at the PHC. The diagnostic evaluation was performed by the physician in the community. Children diagnosed by the physician as having epilepsy were prescribed anti-seizure medication (ASM) and received follow-up care from a physician.~In addition to the usual epilepsy care provided by the physician, each child in the EUC arm was followed by an epilepsy-trained CHW, who followed the child's progress, helped the family navigate the healthcare system (including finding a physician). The usual physician care of epilepsy was enhanced by the support of a CHW, but epilepsy diagnosis and treatment was provided by a physician, not by the epilepsy-trained CHW.
54826OG001

Outcome

Type
SECONDARY
Title
Mortality
Description
Differences in mortality between study arms that cannot be explained by potential differences in disease severity
Time frame
Deaths measured for 25 months after enrollment.
Population
This analysis was performed on the Epilepsy Outcomes Population or those diagnosed with epilepsy who were enrolled in the clinical trial.

Source ClinicalTrials.gov

Trial

Title
Bridging the Childhood Epilepsy Treatment Gap in Africa
NCT number
NCT04290975
Phases
NA
Conditions
Epilepsy
Interventions
Task-shifting epilepsy care to epilepsy-trained community health workers (CHWs), Enhanced usual care for epilepsy (EUC)
Lead sponsor
Vanderbilt University Medical Center
Results first posted
2026-02-20

Source ClinicalTrials.gov

Source

Release
trial-comparisons-2026-03-23-0.1.0
Release manifest SHA-256
f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
AACT copy
2026-03-23
Tables read
outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet

Source ClinicalTrials.gov

Sources 2

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

For software

Read this comparison from software.

The record is JSON. No key.

GET https://conductscience.org/api/comparisons/v1/NCT04290975-0a02008e